{"database": "lobbying", "table": "lobbying_activities", "rows": [[595560, "b93ad7d4-f555-45a7-8074-bc55f62820b5", "Q1", "ALSTON & BIRD LLP", 1182, "MYLAN LABORATORIES", 2008, "first_quarter", "FOR", "H.R. 5501/S. 2731, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008, provisions pertaining to HIV/AIDS drug treatment.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2008-04-17T15:07:36-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["595560"], "units": {}, "query_ms": 0.33282197546213865, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}